1 Chronic migraine is associated with a major global economic burden due to lost productivity from work and healthcare costs. Migraine alone is the leading cause of disability worldwide in patients under the age of 50. Finally, it discusses the management of chronic migraine in special populations, including pediatrics, pregnancy, and older people, and considers future questions and emerging research in the field.Ĭhronic migraine, once called transformed migraine, is a neurologic disorder that causes pain and impaired functioning. It discusses the international guidelines on drug treatment for chronic migraine and evaluates non-drug treatments including behavioral and complementary therapies and lifestyle modifications. It discusses evidence based drug and non-drug treatments, their advantages and disadvantages, and the principles of patient centered care for adults with chronic migraine, with attention to differential diagnosis and comorbidities, clinical reasoning, initiation and monitoring, cost, and availability.
This review outlines the epidemiology of and diagnostic criteria and risk factors for chronic migraine. The past five years have seen a dramatic expansion in new treatments for this often challenging condition, among them calcitonin gene related peptide antagonists and neuromodulatory devices. Chronic migraine is a neurologic disorder associated with considerable disability, lost productivity, and a profound economic burden worldwide.
0 kommentar(er)
